Analysis of survival endpoints (EFS, PFS, CSS, and OS) according to the MALT-IPI risk group in the testing set from the IELSG-19 clinical trial database: Kaplan-Meier estimates
| Risk group . | N . | EFS . | PFS . | CSS . | OS . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-y rate, % (95% CI) . | Median, y . | P . | 5-y rate, % (95% CI) . | Median, y . | P . | 5-y rate, % (95% CI) . | Median, y . | P . | 5-y rate, % (95% CI) . | Median, y . | P . | ||
| Low | 167 | 69.8 (62.0-76.2) | NR | <.0001 | 76.0 (68.3-82.1) | NR | <.0001 | 100 (–) | NR | <.0001 | 98.7 (94.9-99.7) | NR | <.0001 |
| Intermediate | 165 | 55.7 (47.7-63.0) | 6.3 | 63.1 (54.8-70.2) | 9.8 | 98.1 (94.1-99.4) | NR | 93.1 (87.8-96.1) | NR | ||||
| High | 68 | 28.7 (18.4-39.9) | 2.0 | 32.5 (21.2-44.2) | 2.8 | 84.5 (72.3-91.7) | NR | 64.3 (51.3-74.8) | 8.1 | ||||
| Risk group . | N . | EFS . | PFS . | CSS . | OS . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-y rate, % (95% CI) . | Median, y . | P . | 5-y rate, % (95% CI) . | Median, y . | P . | 5-y rate, % (95% CI) . | Median, y . | P . | 5-y rate, % (95% CI) . | Median, y . | P . | ||
| Low | 167 | 69.8 (62.0-76.2) | NR | <.0001 | 76.0 (68.3-82.1) | NR | <.0001 | 100 (–) | NR | <.0001 | 98.7 (94.9-99.7) | NR | <.0001 |
| Intermediate | 165 | 55.7 (47.7-63.0) | 6.3 | 63.1 (54.8-70.2) | 9.8 | 98.1 (94.1-99.4) | NR | 93.1 (87.8-96.1) | NR | ||||
| High | 68 | 28.7 (18.4-39.9) | 2.0 | 32.5 (21.2-44.2) | 2.8 | 84.5 (72.3-91.7) | NR | 64.3 (51.3-74.8) | 8.1 | ||||